SCHEMBL16268635

SCHEMBL16268635

CCNc1cc(Cl)ccc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ POLB P06746 4/20 0.39
▸ LMNA P02545 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GAA P10253 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ ALOX12 P18054 2/20 0.39
▸ MCL1 Q07820 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ GRIK1 P39086 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ NOS3 P29474 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12852098 0.84 SMN1; SMN2 (0.41) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL31544733 0.84 SMN1; SMN2 (0.41) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL3789681 0.81 SMN1; SMN2 (0.44) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL3398998 0.79 MEN1 (0.50) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL1645546 0.78 TSHR (0.60) POLBLMNAALDH1A1GAAMAPT
SCHEMBL14044063 0.78 TSHR (0.41) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL12895731 0.78 ALDH1A1 (0.40) MEN1KMT2ASMN1; SMN2POLBLMNA
Hydrochloric Acid SCHEMBL6518247 0.78 MEN1 (0.48) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL25318451 0.77 SMN1; SMN2 (0.40) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL2018693 0.76 LMNA (0.49) MEN1KMT2ASMN1; SMN2POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3204383-A1 SPIRODIAMINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2017-08-16 — — EP disclosed
WO-2016055394-A1 SPIRODIAMINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2016-04-14 — — WO disclosed
EP-3004089-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F.HOFFMANN-LA ROCHE AG (CH) 2016-04-13 — — EP disclosed
EP-3004076-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2016-04-13 — — EP disclosed
EP-3004077-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2016-04-13 — — EP disclosed
WO-2014191338-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-12-04 — — WO disclosed
WO-2014191340-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-12-04 — — WO disclosed
WO-2014191336-A1 NEW 3,4-DIHYDRO-2H-ISOQUINOLINE-1-ONE AND 2,3-DIHYDRO-ISOINDOL-1-ONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-12-04 — — WO disclosed
Send feedback